Arrayit Corp. (ARYC.OB) Taps DOCRO Inc. to Facilitate Approval of Ovarian Cancer Screening Test OvaDx
The California-based Arrayit Corporation has quickly evolved into a leader in life sciences and the overall healthcare field. Arrayit Corporations subsidiary Arrayit Diagnostics has gained recognition for detecting cancer in early stages which has made them a friend to both investors and cancer patients. Today, Arrayit Corporation took a major step towards enhancing their future with the announcement that they have joined forces with DOCRO, Inc. DOCRO is a renowned contract research organization which specializes in the design and conduct of clinical trials of in vitro diagnostic clearance from the U.S. Food and Drug Administration (FDA). DOCRO has steered close…